Original citation: J Clin Invest. 2016;126(1):254–265. https://doi.org/10.1172/JCI79775
Citation for this expression of concern: J Clin Invest. 2019;129(8):3464 https://doi.org/10.1172/JCI131245
The corresponding author recently notified the JCI that the patient data presented in Figure 1B were not correct. Analysis of the correct patient data set does not show a significant difference in CERS6 expression in human lung adenocarcinomas with positive invasive growth (definite) compared with those with negligible invasive growth or without invasive growth (focal/none). The Editors have requested an institutional investigation into this matter, and we will inform our readers of the outcome when the investigation is complete.
Version 1. 07/02/2019
Electronic publication
Version 2. 08/01/2019
Print issue publication
Footnotes
See the related article at Targeting ceramide synthase 6–dependent metastasis-prone phenotype in lung cancer cells.